Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
OwnerJudith Aronhime, Sandor Molnar +4inventors
InventorsJudith Aronhime, Sandor Molnar, Csaba Szabo, Erzsebet Meszaros Sos, Szabolcs Salyi, Tivadar Tamas
Life of this patent
Estimating the term…
Abstract
Ondansetron crystalline Forms A and B are useful in the treatment of nausea and vomiting. Form B has a uniquely high melting point of about 244° C. and both forms are stable against thermally induced polymorphic transition from 30° C. up to their melting points.
Claims35
A high melting crystalline form of ondansetron characterized by a thermal analysis result indicative of a melting point of 244±2° C.
A crystalline form of ondansetron characterized by a powder X-ray diffraction pattern having peaks at 25.4, 26.7 and 27.8±1.0 degrees two-theta.
Dependencies are inferred from the claim text.